참고문헌
- Downie ML, Lopez Garcia SC, Kleta R, Bockenhauer D. Inherited tubulopathies of the kidney: insights from genetics. Clin J Am Soc Nephrol 2021;16:620-30. https://doi.org/10.2215/CJN.14481119
- Kleta R, Bockenhauer D. Salt-losing tubulopathies in children: what's new, what's controversial? J Am Soc Nephrol 2018;29:727-39. https://doi.org/10.1681/ASN.2017060600
- Kermond R, Mallett A, McCarthy H. A clinical approach to tubulopathies in children and young adults. Pediatr Nephrol 2023;38:651-62. https://doi.org/10.1007/s00467-022-05606-1
- Foreman JW. Fanconi syndrome. Pediatr Clin North Am 2019;66:159-67. https://doi.org/10.1016/j.pcl.2018.09.002
- Walsh SB, Unwin RJ. Renal tubular disorders. Clin Med (Lond) 2012;12:476-9. https://doi.org/10.7861/clinmedicine.12-5-476
- Raina R, Krishnappa V, Das A, Amin H, Radhakrishnan Y, Nair NR, et al. Overview of monogenic or mendelian forms of hypertension. Front Pediatr 2019;7:263.
- Alexander RT, Cordat E, Chambrey R, Dimke H, Eladari D. Acidosis and urinary calcium excretion: insights from genetic disorders. J Am Soc Nephrol 2016;27:3511-20. https://doi.org/10.1681/ASN.2016030305
- Alexander RT, Bitzan M. Renal tubular acidosis. Pediatr Clin North Am 2019;66:135-57. https://doi.org/10.1016/j.pcl.2018.08.011
- Klootwijk ED, Reichold M, Unwin RJ, Kleta R, Warth R, Bockenhauer D. Renal Fanconi syndrome: taking a proximal look at the nephron. Nephrol Dial Transplant 2015;30:1456-60. https://doi.org/10.1093/ndt/gfu377
- Bokenkamp A, Ludwig M. The oculocerebrorenal syndrome of Lowe: an update. Pediatr Nephrol 2016;31:2201-12. https://doi.org/10.1007/s00467-016-3343-3
- De Matteis MA, Staiano L, Emma F, Devuyst O. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. Nat Rev Nephrol 2017;13:455-70. https://doi.org/10.1038/nrneph.2017.83
- Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 2015;10:1257-72. https://doi.org/10.2215/CJN.09750913
- Besouw MT, Kleta R, Bockenhauer D. Bartter and Gitelman syndromes: questions of class. Pediatr Nephrol 2020;35:1815-24. https://doi.org/10.1007/s00467-019-04371-y
- Walsh PR, Tse Y, Ashton E, Iancu D, Jenkins L, Bienias M, et al. Clinical and diagnostic features of Bartter and Gitelman syndromes. Clin Kidney J 2018;11:302-9. https://doi.org/10.1093/ckj/sfx118
- Claverie-Martin F. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics. Clin Kidney J 2015;8:656-64. https://doi.org/10.1093/ckj/sfv081
- Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol 2015;11:576-88. https://doi.org/10.1038/nrneph.2015.89
- Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management: a KDIGO consensus report. Kidney Int 2015;88:676-83. https://doi.org/10.1038/ki.2015.28
- Devuyst O, Olinger E, Weber S, Eckardt KU, Kmoch S, Rampoldi L, et al. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers 2019;5:60.
- Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, et al. Diagnostic utility of exome sequencing for kidney disease. N Engl J Med 2019;380:142-51. https://doi.org/10.1056/NEJMoa1806891
- Bleyer AJ, Wolf MT, Kidd KO, Zivna M, Kmoch S. Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β. Pediatr Nephrol 2022;37:933-46. https://doi.org/10.1007/s00467-021-05118-4
- Sinha R, Pradhan S, Banerjee S, Jahan A, Akhtar S, Pahari A, et al. Whole-exome sequencing and variant spectrum in children with suspected inherited renal tubular disorder: the East India Tubulopathy Gene Study. Pediatr Nephrol 2022;37:1811-36. https://doi.org/10.1007/s00467-021-05388-y
- Ashton EJ, Legrand A, Benoit V, Roncelin I, Venisse A, Zennaro MC, et al. Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies. Kidney Int 2018;93:961-7. https://doi.org/10.1016/j.kint.2017.10.016
- Hildebrandt F. Genetic kidney diseases. Lancet 2010;375:1287-95. https://doi.org/10.1016/S0140-6736(10)60236-X
- Rubin JD, Barry MA. Improving molecular therapy in the kidney. Mol Diagn Ther 2020;24:375-96.
- Chung DC, Fogelgren B, Park KM, Heidenberg J, Zuo X, Huang L, et al. Adeno-associated virus-mediated gene transfer to renal tubule cells via a retrograde ureteral approach. Nephron Extra 2011;1:217-23. https://doi.org/10.1159/000333071
- Cherqui S. Hematopoietic stem cell gene therapy for cystinosis: from bench-to-bedside. Cells 2021;10:3273.
- Cystinosis Research Foundation (CRF) News. Stem Cell Trial Phase I/II Updates by Stephanie Cherqui, PhD [Internet]. CRF; 2022 [cited 2022 Dec 10]. Available from: https://www.cystinosisresearch.org/stem-cell-clinical-trial-update-by-stephanie-cherqui-phd/
- Berquez M, Gadsby JR, Festa BP, Butler R, Jackson SP, Berno V, et al. The phosphoinositide 3-kinase inhibitor alpelisib restores actin organization and improves proximal tubule dysfunction in vitro and in a mouse model of Lowe syndrome and Dent disease. Kidney Int 2020;98:883-96. https://doi.org/10.1016/j.kint.2020.05.040